Business Terms
US Government to Distribute Millions of Free COVID-19 Tests to Schools
The rapid antigen tests will be made available for free to all traditional and charter local education agencies across the US.
The firm said it has secured US Food and Drug Administration breakthrough device designation for its test to classify infections and stratify patients by severe disease risk.
Proteomics International Expects Licensing Deal, Medicare Coverage to Drive PromarkerD Sales in 2024
Premium
The company is making its first major commercial push for its diabetic kidney disease test via a US licensing deal it inked this spring with Sonic Healthcare.
The automated instrument has been available for research use, but its target market will be expanded to include clinical diagnostic applications in the coming months.
Personalis, Tempus Partner to Commercialize Blood-Based Minimal Residual Disease Test
Tempus will market Personalis' NeXT Personal Dx liquid biopsy assay while Personalis completes its clinical validation in more indications.